Showing results (251-260 of 331) with videos related to
Sort By:
Pageof 34
Fundamental & Clinical Pharmacology|January 1, 1988
Bronchospasmolytic effects of RU 42173J Fichelle, E Naline, J L Freslon, et al.Allergy|August 27, 2014
The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitisP Devillier, O Chassany, E Vicaut, et al.Journal of Cardiovascular Pharmacology|April 25, 2000
Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous veinF Stanke-Labesque, J L Cracowski, P Bedouch, et al.International Journal of Biological Macromolecules|February 24, 2019
A marine-sourced fucoidan solution inhibits Toll-like-receptor-3-induced cytokine release by human bronchial epithelial cellsM Dutot, S Grassin-Delyle, H Salvator, et al.Journal of Chromatography|June 29, 1990
Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatographyC Dutot, J Moreau, P Cordonnier, et al.European Journal of Pharmacology|January 29, 2000
Thromboxane A(2) modulates cyclic AMP relaxation and production in human internal mammary arteryJ L Cracowski, F Stanke-Labesque, O Chavanon, et al.Therapie|July 1, 1989
[Influence of surgical biliary pathology on the diffusion of ceftriaxone in the biliary tract]L Guyot, E Naline, J Moreau, et al.Biochemical and Biophysical Research Communications|May 15, 1992
Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonistC Advenier, N Rouissi, Q T Nguyen, et al.The American Review of Respiratory Disease|November 1, 1992
Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptorsC Advenier, E Naline, L Toty, et al.Therapie|January 1, 1991
[Diffusion of minocycline in pulmonary tissue]E Naline, J P Roudière, P Cordonnier, et al.Pageof 34